Unknown

Dataset Information

0

Availability of resources to treat sepsis in Brazil: a random sample of Brazilian institutions.


ABSTRACT: OBJECTIVE:To characterize resource availability from a nationally representative random sample of intensive care units in Brazil. METHODS:A structured online survey of participating units in the Sepsis PREvalence Assessment Database (SPREAD) study, a nationwide 1-day point prevalence survey to assess the burden of sepsis in Brazil, was sent to the medical director of each unit. RESULTS:A representative sample of 277 of the 317 invited units responded to the resources survey. Most of the hospitals had fewer than 500 beds (94.6%) with a median of 14 beds in the intensive care unit. Providing care for public-insured patients was the main source of income in two-thirds of the surveyed units. Own microbiology laboratory was not available for 26.8% of the surveyed intensive care units, and 10.5% did not always have access to blood cultures. Broad spectrum antibiotics were not always available in 10.5% of surveyed units, and 21.3% could not always measure lactate within three hours. Those institutions with a high resource availability (158 units, 57%) were usually larger and preferentially served patients from the private health system compared to institutions without high resource availability. Otherwise, those without high resource availability did not always have broad-spectrum antibiotics (24.4%), vasopressors (4.2%) or crystalloids (7.6%). CONCLUSION:Our study indicates that a relevant number of units cannot perform basic monitoring and therapeutic interventions in septic patients. Our results highlight major opportunities for improvement to adhere to simple but effective interventions in Brazil.

SUBMITTER: Taniguchi LU 

PROVIDER: S-EPMC6649213 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7560159 | BioStudies
2020-01-01 | S-EPMC7427679 | BioStudies
2020-01-01 | S-EPMC7441021 | BioStudies
2012-01-01 | S-EPMC3367487 | BioStudies
2019-01-01 | S-EPMC6649218 | BioStudies
2016-01-01 | S-EPMC4988627 | BioStudies
2020-01-01 | S-EPMC7472675 | BioStudies
2020-01-01 | S-EPMC7722364 | BioStudies
| PRJNA267549 | ENA
2020-01-01 | S-EPMC7264562 | BioStudies